gdc
Cancer ResearchClinical TrialsImmunotherapyPediatric Cancer

Is CAR T-Cell Therapy Safe and Effective?

Claire White discusses the role of the FDA in evaluating new and promising treatments such as CAR T-cell therapy and the complexity of getting approvals.
Video Library – March 6, 2019
Claire White, BSN, RN, CPHON
The Children's Hospital of Philadelphia, Philadelphia, PA
Claire White discusses the role of the FDA in evaluating new and promising treatments such as CAR T-cell therapy and the complexity of getting approvals.
Recommended For You
ImmunotherapyLeukemiaLymphomaPersonalized Medicine
Telling Patients About CAR T-Cell Therapy
By Claire White, BSN, RN, CPHON
Nurse Navigator Claire White describes the way she tells her patients what CAR T-cell therapy is and how it works.
Breast CancerImmunotherapyMetastatic Breast Cancer
Immunotherapy plus Chemotherapy Extends Survival for Patients with Metastatic Triple-Negative Breast Cancer
By Dana Taylor
Triple-negative breast cancer has few treatment options. Promising results from recent clinical trials of immunotherapy combined with chemotherapy in patients with metastatic disease may soon change the way this aggressive cancer is treated. Just after this article was written, the FDA approved this combination for patients with triple-negative breast cancer.
Immunotherapy
Immunotherapy vs Targeted Therapy
By Morganna Freeman, DO, FACP
Dr Morganna Freeman explains the difference between immunotherapies and targeted therapies in plain language for patients to easily understand.
Immunotherapy
Understanding Immunotherapy
By Morganna Freeman, DO, FACP
Dr Morganna Freeman breaks down her methods for explaining immunotherapy to her patients.
Last modified: March 6, 2019

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country